# Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis

> **NCT07187661** · NA · RECRUITING · sponsor: **Khyber Medical University Peshawar** · enrollment: 25 (estimated)

## Conditions studied

- Hemophilia
- Chronic Synovitis

## Interventions

- **DRUG:** Intra-articular Bevacizumab

## Key facts

- **NCT ID:** NCT07187661
- **Lead sponsor:** Khyber Medical University Peshawar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-09
- **Primary completion:** 2026-03-28
- **Final completion:** 2026-04-15
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07187661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07187661, "Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07187661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*